1 Study Coverage
    1.1 Drug-Device Combination Products Product Introduction
    1.2 Market by Type
        1.2.1 Global Drug-Device Combination Products Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Drug-Coated Device
        1.2.3 Prefilled Drug Delivery Systems
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Drug-Device Combination Products Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Drug-Device Combination Products Sales Estimates and Forecasts 2017-2028
    2.2 Global Drug-Device Combination Products Revenue Estimates and Forecasts 2017-2028
    2.3 Global Drug-Device Combination Products Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Drug-Device Combination Products Sales by Region
        2.4.1 Global Drug-Device Combination Products Sales by Region (2017-2022)
        2.4.2 Global Sales Drug-Device Combination Products by Region (2023-2028)
    2.5 Global Drug-Device Combination Products Revenue by Region
        2.5.1 Global Drug-Device Combination Products Revenue by Region (2017-2022)
        2.5.2 Global Drug-Device Combination Products Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Drug-Device Combination Products Sales by Manufacturers
        3.1.1 Global Top Drug-Device Combination Products Manufacturers by Sales (2017-2022)
        3.1.2 Global Drug-Device Combination Products Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drug-Device Combination Products in 2021
    3.2 Global Drug-Device Combination Products Revenue by Manufacturers
        3.2.1 Global Drug-Device Combination Products Revenue by Manufacturers (2017-2022)
        3.2.2 Global Drug-Device Combination Products Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Drug-Device Combination Products Revenue in 2021
    3.3 Global Drug-Device Combination Products Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Drug-Device Combination Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Drug-Device Combination Products Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Drug-Device Combination Products Sales by Type
        4.1.1 Global Drug-Device Combination Products Historical Sales by Type (2017-2022)
        4.1.2 Global Drug-Device Combination Products Forecasted Sales by Type (2023-2028)
        4.1.3 Global Drug-Device Combination Products Sales Market Share by Type (2017-2028)
    4.2 Global Drug-Device Combination Products Revenue by Type
        4.2.1 Global Drug-Device Combination Products Historical Revenue by Type (2017-2022)
        4.2.2 Global Drug-Device Combination Products Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Drug-Device Combination Products Revenue Market Share by Type (2017-2028)
    4.3 Global Drug-Device Combination Products Price by Type
        4.3.1 Global Drug-Device Combination Products Price by Type (2017-2022)
        4.3.2 Global Drug-Device Combination Products Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Drug-Device Combination Products Sales by Application
        5.1.1 Global Drug-Device Combination Products Historical Sales by Application (2017-2022)
        5.1.2 Global Drug-Device Combination Products Forecasted Sales by Application (2023-2028)
        5.1.3 Global Drug-Device Combination Products Sales Market Share by Application (2017-2028)
    5.2 Global Drug-Device Combination Products Revenue by Application
        5.2.1 Global Drug-Device Combination Products Historical Revenue by Application (2017-2022)
        5.2.2 Global Drug-Device Combination Products Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Drug-Device Combination Products Revenue Market Share by Application (2017-2028)
    5.3 Global Drug-Device Combination Products Price by Application
        5.3.1 Global Drug-Device Combination Products Price by Application (2017-2022)
        5.3.2 Global Drug-Device Combination Products Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Drug-Device Combination Products Market Size by Type
        6.1.1 North America Drug-Device Combination Products Sales by Type (2017-2028)
        6.1.2 North America Drug-Device Combination Products Revenue by Type (2017-2028)
    6.2 North America Drug-Device Combination Products Market Size by Application
        6.2.1 North America Drug-Device Combination Products Sales by Application (2017-2028)
        6.2.2 North America Drug-Device Combination Products Revenue by Application (2017-2028)
    6.3 North America Drug-Device Combination Products Market Size by Country
        6.3.1 North America Drug-Device Combination Products Sales by Country (2017-2028)
        6.3.2 North America Drug-Device Combination Products Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Drug-Device Combination Products Market Size by Type
        7.1.1 Europe Drug-Device Combination Products Sales by Type (2017-2028)
        7.1.2 Europe Drug-Device Combination Products Revenue by Type (2017-2028)
    7.2 Europe Drug-Device Combination Products Market Size by Application
        7.2.1 Europe Drug-Device Combination Products Sales by Application (2017-2028)
        7.2.2 Europe Drug-Device Combination Products Revenue by Application (2017-2028)
    7.3 Europe Drug-Device Combination Products Market Size by Country
        7.3.1 Europe Drug-Device Combination Products Sales by Country (2017-2028)
        7.3.2 Europe Drug-Device Combination Products Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Drug-Device Combination Products Market Size by Type
        8.1.1 Asia Pacific Drug-Device Combination Products Sales by Type (2017-2028)
        8.1.2 Asia Pacific Drug-Device Combination Products Revenue by Type (2017-2028)
    8.2 Asia Pacific Drug-Device Combination Products Market Size by Application
        8.2.1 Asia Pacific Drug-Device Combination Products Sales by Application (2017-2028)
        8.2.2 Asia Pacific Drug-Device Combination Products Revenue by Application (2017-2028)
    8.3 Asia Pacific Drug-Device Combination Products Market Size by Region
        8.3.1 Asia Pacific Drug-Device Combination Products Sales by Region (2017-2028)
        8.3.2 Asia Pacific Drug-Device Combination Products Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Drug-Device Combination Products Market Size by Type
        9.1.1 Latin America Drug-Device Combination Products Sales by Type (2017-2028)
        9.1.2 Latin America Drug-Device Combination Products Revenue by Type (2017-2028)
    9.2 Latin America Drug-Device Combination Products Market Size by Application
        9.2.1 Latin America Drug-Device Combination Products Sales by Application (2017-2028)
        9.2.2 Latin America Drug-Device Combination Products Revenue by Application (2017-2028)
    9.3 Latin America Drug-Device Combination Products Market Size by Country
        9.3.1 Latin America Drug-Device Combination Products Sales by Country (2017-2028)
        9.3.2 Latin America Drug-Device Combination Products Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Drug-Device Combination Products Market Size by Type
        10.1.1 Middle East and Africa Drug-Device Combination Products Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Drug-Device Combination Products Revenue by Type (2017-2028)
    10.2 Middle East and Africa Drug-Device Combination Products Market Size by Application
        10.2.1 Middle East and Africa Drug-Device Combination Products Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Drug-Device Combination Products Revenue by Application (2017-2028)
    10.3 Middle East and Africa Drug-Device Combination Products Market Size by Country
        10.3.1 Middle East and Africa Drug-Device Combination Products Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Drug-Device Combination Products Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Polyzen
        11.1.1 Polyzen Corporation Information
        11.1.2 Polyzen Overview
        11.1.3 Polyzen Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Polyzen Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Polyzen Recent Developments
    11.2 Kaleo
        11.2.1 Kaleo Corporation Information
        11.2.2 Kaleo Overview
        11.2.3 Kaleo Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Kaleo Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Kaleo Recent Developments
    11.3 Terumo Corporation
        11.3.1 Terumo Corporation Corporation Information
        11.3.2 Terumo Corporation Overview
        11.3.3 Terumo Corporation Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Terumo Corporation Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Terumo Corporation Recent Developments
    11.4 Nuventra
        11.4.1 Nuventra Corporation Information
        11.4.2 Nuventra Overview
        11.4.3 Nuventra Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Nuventra Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Nuventra Recent Developments
    11.5 Antares
        11.5.1 Antares Corporation Information
        11.5.2 Antares Overview
        11.5.3 Antares Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Antares Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Antares Recent Developments
    11.6 Novus Therapeutics
        11.6.1 Novus Therapeutics Corporation Information
        11.6.2 Novus Therapeutics Overview
        11.6.3 Novus Therapeutics Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Novus Therapeutics Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Novus Therapeutics Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Drug-Device Combination Products Industry Chain Analysis
    12.2 Drug-Device Combination Products Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Drug-Device Combination Products Production Mode & Process
    12.4 Drug-Device Combination Products Sales and Marketing
        12.4.1 Drug-Device Combination Products Sales Channels
        12.4.2 Drug-Device Combination Products Distributors
    12.5 Drug-Device Combination Products Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Drug-Device Combination Products Industry Trends
    13.2 Drug-Device Combination Products Market Drivers
    13.3 Drug-Device Combination Products Market Challenges
    13.4 Drug-Device Combination Products Market Restraints
14 Key Findings in The Global Drug-Device Combination Products Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Drug-Device Combination Products Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Drug-Coated Device
    Table 3. Major Manufacturers of Prefilled Drug Delivery Systems
    Table 4. Major Manufacturers of Others
    Table 5. Global Drug-Device Combination Products Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Drug-Device Combination Products Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Drug-Device Combination Products Sales by Region (2017-2022) & (K Units)
    Table 8. Global Drug-Device Combination Products Sales Market Share by Region (2017-2022)
    Table 9. Global Drug-Device Combination Products Sales by Region (2023-2028) & (K Units)
    Table 10. Global Drug-Device Combination Products Sales Market Share by Region (2023-2028)
    Table 11. Global Drug-Device Combination Products Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Drug-Device Combination Products Revenue Market Share by Region (2017-2022)
    Table 13. Global Drug-Device Combination Products Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Drug-Device Combination Products Revenue Market Share by Region (2023-2028)
    Table 15. Global Drug-Device Combination Products Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Drug-Device Combination Products Sales Share by Manufacturers (2017-2022)
    Table 17. Global Drug-Device Combination Products Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Drug-Device Combination Products Revenue Share by Manufacturers (2017-2022)
    Table 19. Drug-Device Combination Products Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Drug-Device Combination Products Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Drug-Device Combination Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Device Combination Products as of 2021)
    Table 22. Drug-Device Combination Products Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Drug-Device Combination Products Product Offered
    Table 24. Date of Manufacturers Enter into Drug-Device Combination Products Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Drug-Device Combination Products Sales by Type (2017-2022) & (K Units)
    Table 27. Global Drug-Device Combination Products Sales by Type (2023-2028) & (K Units)
    Table 28. Global Drug-Device Combination Products Sales Share by Type (2017-2022)
    Table 29. Global Drug-Device Combination Products Sales Share by Type (2023-2028)
    Table 30. Global Drug-Device Combination Products Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Drug-Device Combination Products Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Drug-Device Combination Products Revenue Share by Type (2017-2022)
    Table 33. Global Drug-Device Combination Products Revenue Share by Type (2023-2028)
    Table 34. Drug-Device Combination Products Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Drug-Device Combination Products Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Drug-Device Combination Products Sales by Application (2017-2022) & (K Units)
    Table 37. Global Drug-Device Combination Products Sales by Application (2023-2028) & (K Units)
    Table 38. Global Drug-Device Combination Products Sales Share by Application (2017-2022)
    Table 39. Global Drug-Device Combination Products Sales Share by Application (2023-2028)
    Table 40. Global Drug-Device Combination Products Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Drug-Device Combination Products Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Drug-Device Combination Products Revenue Share by Application (2017-2022)
    Table 43. Global Drug-Device Combination Products Revenue Share by Application (2023-2028)
    Table 44. Drug-Device Combination Products Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Drug-Device Combination Products Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Drug-Device Combination Products Sales by Type (2017-2022) & (K Units)
    Table 47. North America Drug-Device Combination Products Sales by Type (2023-2028) & (K Units)
    Table 48. North America Drug-Device Combination Products Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Drug-Device Combination Products Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Drug-Device Combination Products Sales by Application (2017-2022) & (K Units)
    Table 51. North America Drug-Device Combination Products Sales by Application (2023-2028) & (K Units)
    Table 52. North America Drug-Device Combination Products Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Drug-Device Combination Products Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Drug-Device Combination Products Sales by Country (2017-2022) & (K Units)
    Table 55. North America Drug-Device Combination Products Sales by Country (2023-2028) & (K Units)
    Table 56. North America Drug-Device Combination Products Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Drug-Device Combination Products Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Drug-Device Combination Products Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Drug-Device Combination Products Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Drug-Device Combination Products Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Drug-Device Combination Products Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Drug-Device Combination Products Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Drug-Device Combination Products Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Drug-Device Combination Products Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Drug-Device Combination Products Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Drug-Device Combination Products Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Drug-Device Combination Products Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Drug-Device Combination Products Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Drug-Device Combination Products Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Drug-Device Combination Products Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Drug-Device Combination Products Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Drug-Device Combination Products Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Drug-Device Combination Products Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Drug-Device Combination Products Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Drug-Device Combination Products Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Drug-Device Combination Products Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Drug-Device Combination Products Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Drug-Device Combination Products Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Drug-Device Combination Products Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Drug-Device Combination Products Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Drug-Device Combination Products Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Drug-Device Combination Products Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Drug-Device Combination Products Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Drug-Device Combination Products Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Drug-Device Combination Products Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Drug-Device Combination Products Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Drug-Device Combination Products Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Drug-Device Combination Products Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Drug-Device Combination Products Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Drug-Device Combination Products Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Drug-Device Combination Products Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Drug-Device Combination Products Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Drug-Device Combination Products Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Drug-Device Combination Products Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Drug-Device Combination Products Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Drug-Device Combination Products Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Drug-Device Combination Products Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Drug-Device Combination Products Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Drug-Device Combination Products Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Drug-Device Combination Products Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Drug-Device Combination Products Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Drug-Device Combination Products Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Drug-Device Combination Products Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Drug-Device Combination Products Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Drug-Device Combination Products Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Polyzen Corporation Information
    Table 107. Polyzen Description and Major Businesses
    Table 108. Polyzen Drug-Device Combination Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Polyzen Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Polyzen Recent Developments
    Table 111. Kaleo Corporation Information
    Table 112. Kaleo Description and Major Businesses
    Table 113. Kaleo Drug-Device Combination Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Kaleo Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Kaleo Recent Developments
    Table 116. Terumo Corporation Corporation Information
    Table 117. Terumo Corporation Description and Major Businesses
    Table 118. Terumo Corporation Drug-Device Combination Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Terumo Corporation Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Terumo Corporation Recent Developments
    Table 121. Nuventra Corporation Information
    Table 122. Nuventra Description and Major Businesses
    Table 123. Nuventra Drug-Device Combination Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Nuventra Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Nuventra Recent Developments
    Table 126. Antares Corporation Information
    Table 127. Antares Description and Major Businesses
    Table 128. Antares Drug-Device Combination Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Antares Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Antares Recent Developments
    Table 131. Novus Therapeutics Corporation Information
    Table 132. Novus Therapeutics Description and Major Businesses
    Table 133. Novus Therapeutics Drug-Device Combination Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Novus Therapeutics Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Novus Therapeutics Recent Developments
    Table 136. Key Raw Materials Lists
    Table 137. Raw Materials Key Suppliers Lists
    Table 138. Drug-Device Combination Products Distributors List
    Table 139. Drug-Device Combination Products Customers List
    Table 140. Drug-Device Combination Products Market Trends
    Table 141. Drug-Device Combination Products Market Drivers
    Table 142. Drug-Device Combination Products Market Challenges
    Table 143. Drug-Device Combination Products Market Restraints
    Table 144. Research Programs/Design for This Report
    Table 145. Key Data Information from Secondary Sources
    Table 146. Key Data Information from Primary Sources
List of Figures
    Figure 1. Drug-Device Combination Products Product Picture
    Figure 3. Global Drug-Device Combination Products Market Share by Type in 2021 & 2028
    Figure 3. Drug-Coated Device Product Picture
    Figure 4. Prefilled Drug Delivery Systems Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Drug-Device Combination Products Market Share by Application in 2021 & 2028
    Figure 7. Hospital
    Figure 8. Clinic
    Figure 9. Others
    Figure 10. Drug-Device Combination Products Report Years Considered
    Figure 11. Global Drug-Device Combination Products Sales 2017-2028 (K Units)
    Figure 12. Global Drug-Device Combination Products Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Drug-Device Combination Products Revenue 2017-2028 (US$ Million)
    Figure 14. Global Drug-Device Combination Products Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Drug-Device Combination Products Sales Market Share by Region (2017-2022)
    Figure 16. Global Drug-Device Combination Products Sales Market Share by Region (2023-2028)
    Figure 17. North America Drug-Device Combination Products Sales YoY (2017-2028) & (K Units)
    Figure 18. North America Drug-Device Combination Products Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Drug-Device Combination Products Sales YoY (2017-2028) & (K Units)
    Figure 20. Europe Drug-Device Combination Products Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Drug-Device Combination Products Sales YoY (2017-2028) & (K Units)
    Figure 22. Asia-Pacific Drug-Device Combination Products Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Drug-Device Combination Products Sales YoY (2017-2028) & (K Units)
    Figure 24. Latin America Drug-Device Combination Products Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Drug-Device Combination Products Sales YoY (2017-2028) & (K Units)
    Figure 26. Middle East & Africa Drug-Device Combination Products Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Drug-Device Combination Products Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Drug-Device Combination Products in the World: Market Share by Drug-Device Combination Products Revenue in 2021
    Figure 29. Global Drug-Device Combination Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Drug-Device Combination Products Sales Market Share by Type (2017-2028)
    Figure 31. Global Drug-Device Combination Products Revenue Market Share by Type (2017-2028)
    Figure 32. Global Drug-Device Combination Products Sales Market Share by Application (2017-2028)
    Figure 33. Global Drug-Device Combination Products Revenue Market Share by Application (2017-2028)
    Figure 34. North America Drug-Device Combination Products Sales Market Share by Type (2017-2028)
    Figure 35. North America Drug-Device Combination Products Revenue Market Share by Type (2017-2028)
    Figure 36. North America Drug-Device Combination Products Sales Market Share by Application (2017-2028)
    Figure 37. North America Drug-Device Combination Products Revenue Market Share by Application (2017-2028)
    Figure 38. North America Drug-Device Combination Products Sales Share by Country (2017-2028)
    Figure 39. North America Drug-Device Combination Products Revenue Share by Country (2017-2028)
    Figure 40. U.S. Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Drug-Device Combination Products Sales Market Share by Type (2017-2028)
    Figure 43. Europe Drug-Device Combination Products Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Drug-Device Combination Products Sales Market Share by Application (2017-2028)
    Figure 45. Europe Drug-Device Combination Products Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Drug-Device Combination Products Sales Share by Country (2017-2028)
    Figure 47. Europe Drug-Device Combination Products Revenue Share by Country (2017-2028)
    Figure 48. Germany Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 49. France Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Drug-Device Combination Products Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Drug-Device Combination Products Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Drug-Device Combination Products Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Drug-Device Combination Products Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Drug-Device Combination Products Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Drug-Device Combination Products Revenue Share by Region (2017-2028)
    Figure 59. China Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 62. India Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Drug-Device Combination Products Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Drug-Device Combination Products Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Drug-Device Combination Products Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Drug-Device Combination Products Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Drug-Device Combination Products Sales Share by Country (2017-2028)
    Figure 74. Latin America Drug-Device Combination Products Revenue Share by Country (2017-2028)
    Figure 75. Mexico Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Drug-Device Combination Products Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Drug-Device Combination Products Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Drug-Device Combination Products Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Drug-Device Combination Products Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Drug-Device Combination Products Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Drug-Device Combination Products Revenue Share by Country (2017-2028)
    Figure 84. Turkey Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 86. U.A.E Drug-Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 87. Drug-Device Combination Products Value Chain
    Figure 88. Drug-Device Combination Products Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed